Why this grouping
Grouped on the shared TDP-43 proteinopathy mechanism: members conform to the tdp43_proteinopathy module, with cytoplasmic TDP-43 aggregation and, when modeled, nuclear RNA-processing loss acting as a convergent neurodegenerative lesion. The members are kept distinct because their upstream triggers and clinical-anatomic presentations differ: ALS is a motor-neuron degeneration syndrome with genetic and sporadic subtypes, ALS-PDC is a Western Pacific parkinsonism-dementia-motor neuron complex, and CTE is associated with repetitive head impacts and includes TDP-43 pathology in a subset of cases.
Membership criteria
NECESSARY AND SUFFICIENT (member ⇔ criteria)
A disorder belongs to this grouping if and only if it conforms to the TDP-43 proteinopathy module, capturing cytoplasmic TDP-43 aggregation and/or nuclear loss of TDP-43 RNA-processing function as a disease mechanism.
- CONFORMS TO MODULE
module: tdp43_proteinopathy
Conforms to the TDP-43 proteinopathy module.
Coverage and gaps
3 rows
Exact MONDO scope not assessed
3 listed with MONDO ID
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Conforms to the TDP-43 proteinopathy module. |
|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex
DISEASE
Differentiating mechanismALS-PDC combines motor neuron disease, parkinsonism, and dementia in a long-latency Western Pacific neurodegenerative syndrome, with TDP-43 aggregation modeled alongside environmental and excitotoxic contributors.
inclusion body assembly GO:0070841
|
Guam amyotrophic lateral sclerosis-parkinsonism-dementia complex
MONDO:0007104
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Amyotrophic Lateral Sclerosis
DISEASE
Differentiating mechanismALS places TDP-43 pathology in vulnerable upper and lower motor neurons, with TARDBP, C9orf72, SOD1-negative/FUS-negative sporadic biology, and downstream STMN2/UNC13A RNA-processing defects contributing to the motor neuron degeneration phenotype.
TARDBP hgnc:11571
|
amyotrophic lateral sclerosis
MONDO:0004976
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Chronic Traumatic Encephalopathy
DISEASE
Differentiating mechanismCTE is distinguished by repetitive-head-impact exposure and a primary tauopathy context; it enters this grouping because the curated mechanism includes cytoplasmic TDP-43 aggregation as a co-pathology in a subset of disease.
inclusion body assembly GO:0070841
|
chronic traumatic encephalopathy
MONDO:0043512
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
Source
View YAML on GitHubRaw YAML
name: TDP-43 Proteinopathies
display_name: TDP-43 Proteinopathies
creation_date: "2026-06-18T00:00:00Z"
description: >-
TDP-43 proteinopathies are neurodegenerative disorders whose mechanism graphs
include pathological redistribution of TDP-43 from the nucleus to the
cytoplasm, cytoplasmic TDP-43 aggregation, and/or nuclear loss of TDP-43
RNA-processing function. The current DisMech grouping spans motor-neuron,
parkinsonism-dementia, and repetitive-head-trauma-associated entries that
declare conformance to the tdp43_proteinopathy module.
grouping_basis:
- SHARED_MECHANISM
- SHARED_PATHWAY
grouping_rationale: >-
Grouped on the shared TDP-43 proteinopathy mechanism: members conform to the
tdp43_proteinopathy module, with cytoplasmic TDP-43 aggregation and, when
modeled, nuclear RNA-processing loss acting as a convergent neurodegenerative
lesion. The members are kept distinct because their upstream triggers and
clinical-anatomic presentations differ: ALS is a motor-neuron degeneration
syndrome with genetic and sporadic subtypes, ALS-PDC is a Western Pacific
parkinsonism-dementia-motor neuron complex, and CTE is associated with
repetitive head impacts and includes TDP-43 pathology in a subset of cases.
membership_criteria:
- description: >-
A disorder belongs to this grouping if and only if it conforms to the
TDP-43 proteinopathy module, capturing cytoplasmic TDP-43 aggregation and/or
nuclear loss of TDP-43 RNA-processing function as a disease mechanism.
criteria_semantics: NECESSARY_AND_SUFFICIENT
logic:
criterion_predicate: CONFORMS_TO_MODULE
module: tdp43_proteinopathy
description: >-
Conforms to the TDP-43 proteinopathy module.
members:
- member: Amyotrophic Lateral Sclerosis
member_type: DISEASE
differentiating_mechanisms:
- description: >-
ALS places TDP-43 pathology in vulnerable upper and lower motor neurons,
with TARDBP, C9orf72, SOD1-negative/FUS-negative sporadic biology, and
downstream STMN2/UNC13A RNA-processing defects contributing to the motor
neuron degeneration phenotype.
gene:
preferred_term: TARDBP
term:
id: hgnc:11571
label: TARDBP
- member: Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex
member_type: DISEASE
differentiating_mechanisms:
- description: >-
ALS-PDC combines motor neuron disease, parkinsonism, and dementia in a
long-latency Western Pacific neurodegenerative syndrome, with TDP-43
aggregation modeled alongside environmental and excitotoxic contributors.
biological_processes:
- preferred_term: inclusion body assembly
term:
id: GO:0070841
label: inclusion body assembly
modifier: INCREASED
- member: Chronic Traumatic Encephalopathy
member_type: DISEASE
differentiating_mechanisms:
- description: >-
CTE is distinguished by repetitive-head-impact exposure and a primary
tauopathy context; it enters this grouping because the curated mechanism
includes cytoplasmic TDP-43 aggregation as a co-pathology in a subset of
disease.
biological_processes:
- preferred_term: inclusion body assembly
term:
id: GO:0070841
label: inclusion body assembly
modifier: INCREASED
notes: >-
This grouping intentionally avoids also adding a separate glutamate
excitotoxicity grouping in the same change, because the current DisMech ALS
entries would overlap heavily across both groupings.